Overcoming problematic growth phenotypes in organoids from patients with monogenic GI disease.

Abstract excerpt

Patient-derived organoids provide a unique model system to explore disease-causing mutations ex vivo. By using organoids from duodenal or colonic biopsies of pediatric patients with intestinal epithelial disorders, we can directly assay the patient cells to tailor treatment to their unique disease state. The advent of organoid technology from patients with severe intestinal disorders such as Congenital Diarrhea...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Colon
• Share to Drug Combinations
• Share to Duodenum